Compounds > tetraethylammonium
Page last updated: 2024-08-16

tetraethylammonium and oxidopamine

tetraethylammonium has been researched along with oxidopamine in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19901 (20.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's3 (60.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lim, SP; Muir, TC1
Aizenman, E; Jefferson, BS; Levitan, ES; Mortensen, OV; Redman, PT; Torres, GE; Ziegler, CB1
Faraji, A; Fraidouni, N; Hadibeygi, E; Haghdoost-Yazdi, H; Movahedi, M; Vaezi, F1
Alipour Heidari, M; Dargahi, T; Faraji, A; Fraidouni, N; Haghdoost-Yazdi, H; Mahmudi, M; Piri, H1
Alipour Heidari, M; Dargahi, T; Faraji, A; Fraidouni, N; Haghdoost-Yazdi, H; Najafipour, R; Piri, H1

Other Studies

5 other study(ies) available for tetraethylammonium and oxidopamine

ArticleYear
Mechanisms underlying the electrical and mechanical responses of the guinea-pig internal anal sphincter to field stimulation and to drugs.
    British journal of pharmacology, 1985, Volume: 86, Issue:2

    Topics: Anal Canal; Animals; Calcium; Electric Stimulation; Evoked Potentials; Guinea Pigs; Hydroxydopamines; In Vitro Techniques; Membrane Potentials; Muscle Contraction; Muscles; Oxidopamine; Potassium Chloride; Tetraethylammonium; Tetraethylammonium Compounds

1985
A vital role for voltage-dependent potassium channels in dopamine transporter-mediated 6-hydroxydopamine neurotoxicity.
    Neuroscience, 2006, Nov-17, Volume: 143, Issue:1

    Topics: Adrenergic Agents; Analysis of Variance; Animals; Apoptosis; Cells, Cultured; Cerebral Cortex; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Drug Interactions; Electric Stimulation; Embryo, Mammalian; Green Fluorescent Proteins; Membrane Potentials; Neurons; Oxidopamine; Patch-Clamp Techniques; Potassium Channel Blockers; Potassium Channels, Voltage-Gated; Rats; Tetraethylammonium; Transfection

2006
Significant effects of 4-aminopyridine and tetraethylammonium in the treatment of 6-hydroxydopamine-induced Parkinson's disease.
    Behavioural brain research, 2011, Sep-30, Volume: 223, Issue:1

    Topics: 4-Aminopyridine; Animals; Apomorphine; Behavior, Animal; Disease Models, Animal; Drug Interactions; Male; Medial Forebrain Bundle; Microinjections; Oxidopamine; Parkinson Disease, Secondary; Potassium Channel Blockers; Rats; Rats, Wistar; Tetraethylammonium

2011
Pretreatment with potassium channel blockers of 4-aminopyridine and tetraethylammonium attenuates behavioural symptoms of Parkinsonism induced by intrastriatal injection of 6-hydroxydopamine; the role of lipid peroxidation.
    Neurological research, 2016, Volume: 38, Issue:4

    Topics: 4-Aminopyridine; Adrenergic Agents; Animals; Apomorphine; Corpus Striatum; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Functional Laterality; Male; Mental Disorders; Motor Activity; Oxidopamine; Parkinsonian Disorders; Postural Balance; Potassium Channel Blockers; Rats; Rats, Wistar; Tetraethylammonium; Thiazolidinediones

2016
Blockade of fast A-type and TEA-sensitive potassium channels provide an antiparkinsonian effect in a 6-OHDA animal model.
    Neurosciences (Riyadh, Saudi Arabia), 2017, Volume: 22, Issue:1

    Topics: 4-Aminopyridine; Animals; Antiparkinson Agents; Apomorphine; Dose-Response Relationship, Drug; Drug Synergism; Male; Malondialdehyde; Medial Forebrain Bundle; Neuroprotective Agents; Oxidopamine; Parkinson Disease, Secondary; Potassium Channel Blockers; Rats; Rotarod Performance Test; Tetraethylammonium

2017